Back to search

Belgium· BE-AMP-SAM516933-00

Symtuza 800 mg - 150 mg - 200 mg - 10 mg

A emtricitabine, tenofovir alafenamide, darunavir and cobicistat product containing cobicistat, registered in Belgium by Janssen-Cilag International. The same ATC class is registered in 12 of our 19 countries.

ATC J05AR22

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedSymtuza 800 mg - 150 mg - 200 mg - 10…ATCJ05AR22REGISTER NO.BE-AMP-SAM516933-00PACKS LISTED4CHECKEDSeptember 26, 2026

Where it is registered

Emtricitabine, tenofovir alafenamide, darunavir and cobicistat is registered in 12 of 19 countries.

Countries holding a registration under ATC J05AR22 (emtricitabine, tenofovir alafenamide, darunavir and cobicistat), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Emtricitabine, tenofovir alafenamide, darunavir and cobicistat · ATC J05AR22

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Cobicistat
Manufacturer
Janssen-Cilag International
Country
Belgium (BE)
ATC code
J05AR22
ATC class
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 4

2 priced
  • be_apb
    3667136
    EUR 827.6
  • be_apb
    4235487
    EUR 769.73
  • be_apb
    7722283
  • be_apb
    7728629

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emtricitabine, tenofovir alafenamide, darunavir and cobicistat in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, tenofovir alafenamide, darunavir and cobicistat products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Tybost
  • Liechtenstein · Tybost
  • Norway · Tybost

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/add5f849-0d6b-4326-9685-163b1fad058c
GET /v1/drugs/add5f849-0d6b-4326-9685-163b1fad058c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Symtuza 800 mg - 150 mg - 200 mg - 10 mg",
  "name_fr": "Symtuza 800 mg - 150 mg - 200 mg - 10 mg",
  "name_nl": "Symtuza 800 mg - 150 mg - 200 mg - 10 mg",
  "amp_code": "SAM516933-00",
  "strengths": [
    "150.0000",
    "800.0000",
    "150.0000",
    "200.0000",
    "800.0000",
    "200.0000",
    "800.0000",
    "10.0000",
    "10.0000",
    "10.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Cobicistat",
    "Darunavir Ethanolate",
    "Darunavir",
    "Emtricitabine",
    "Tenofovir Alafenamide Fumarate",
    "Tenofovir Alafenamide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Emtricitabine, Tenofovir Alafenamide, Darunavir and Cobicistat",
  "authorisation_numbers": [
    "EU/1/17/1225/001",
    "EU/1/17/1225/002"
  ]
}

See everything about emtricitabine, tenofovir alafenamide, darunavir and cobicistat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.